Short-term and long-term outcomes of on-pump beating-heart coronary artery bypass surgery in dialysis and non-dialysis patients: a retrospective study in a single center
verfasst von:
Chia-Hsun Lin, Yen‐Yang Chen, Yu‐Tong Yen, Patrick Hung‐Ju Kao, Chai-Hock Chua, Hung-Hsing Chao, Ming-Jen Lu
This study aimed to evaluate the short-term and long-term outcomes of dialysis and non-dialysis patients after On-pump beating-heart coronary artery bypass grafting (OPBH-CABG).
Methods
We retrospectively reviewed medical records of 659 patients underwent OPBH-CABG at our hospital from 2009 to 2019, including 549 non-dialysis patients and 110 dialysis patients. Outcomes were in-hospital mortality, length of stay, surgical complications, post-CABG reintervention, and late mortality. The median follow-up was 3.88 years in non-dialysis patients and 2.24 years in dialysis patients. Propensity matching analysis was performed.
Results
After 1:1 matching, dialysis patients had significantly longer length of stay (14 (11–18) vs. 12 (10–15), p = 0.016), higher rates of myocardial infarction (16.85% vs. 6.74%, p = 0.037) and late mortality (25.93% vs. 9.4%, p = 0.005) after CABG compared to non-dialysis patients. No significant differences were observed in in-hospital mortality, complications, or post-CABG reintervention rate between dialysis and non-dialysis groups.
Conclusions
OPBH-CABG could achieve comparable surgical mortality, surgical complication rates, and long-term revascularization in dialysis patients as those in non-dialysis patients. The results show that OPBH-CABG is a safe and effective surgical option for dialysis patients.
Hinweise
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CABG
Coronary artery bypass grafting
HD
Hemodialysis
ITA
Internal thoracic artery
IABP
Intra-aortic blood pump
PCI
Percutaneous coronary intervention
MI
Myocardial infarction
SD
Standard deviation
IQR
Interquartile range
CIs
Confidence intervals
HR
Hazard ratio
PAOD
Peripheral artery occlusive disease
EF
Ejection fraction
CCS
Canadian cardiovascular society
BITA
Bilateral internal thoracic arteries
Background
Patients on dialysis have high risks for coronary artery diseases and displayed poor prognosis after coronary artery bypass grafting (CABG) compared to non-dialysis patients, including higher surgical mortality, postoperative complications, readmission rate, revascularization, and lower survival [1‐5]. On-pump heart-beating CABG is a hybrid surgical approach maintaining stable hemodynamics with the support of cardiopulmonary bypass, but without cardioplegic arrest and aortic cross-clamping [6]. This may lead to lower myocardial injury, therefore is an option for patients with high-risk profiles. However, its outcomes in different high-risk groups remain further investigation. The purpose of this study was to evaluate short-term and long-term outcomes in dialysis and non-dialysis patients after on-pump beating-heart CABG.
Methods
Patients
This retrospective study enrolled patients underwent coronary artery on-pump beating-heart bypass surgery in our hospital between 2009 and 2019. Inclusion criteria were: 1) with coronary artery disease; 2) indicated for CABG surgery. No exclusion criteria. All necessary information was reviewed from medical record, including demography, clinical characteristics, and postoperative complications. The study was approved by the institutional review board, and the requirement of informed consent was waived.
Anzeige
Operative procedure of on-pump beating heart CABG and renal management
Our perioperative management of renal replacement therapy were as follows: 1) low-potassium hemodialysis (HD) for consecutive 3 days before operation; 2) only hemofiltration during bypass; 3) start of regular intermittent HD on the first postoperative day, followed by regular intermittent HD three times a week.
CABG was performed with a median sternotomy. A partial cardiopulmonary bypass was used. The left anterior descending (LAD) artery was anastomosed with left or right ITA graft. The non-LAD coronary arteries were grafted with a sequential saphenous vein graft (SVG). The distal end of SVG was anastomosed to ascending aorta using partially side-clamping of aorta. Intra-aortic blood pump (IABP) was used liberally pre- or post-operatively in patients with hemodynamic instability, unstable cardiac rhythms, or poor LV function.
Outcomes
Short-term outcomes were in-hospital mortality, length of stay, surgical complications. Long-term outcomes were adverse cardiac events, percutaneous coronary intervention (PCI) reintervention, and late mortality during follow-up. Adverse cardiac events included recurrent angina and myocardial infarction (MI). Late mortality is defined as death during follow-up.
Statistical analysis
Continuous data with a normal distribution were analyzed by Student’s t-test and are presented as the mean ± standard deviation (SD); continuous data without a normal distribution are presented as the median (interquartile range (IQR)) and were analyzed by the Wilcoxon rank-sum test. Normal distribution of variables was tested by Shapiro–Wilk. Categorical data were analyzed with the chi-square test or Fisher’s exact test and are presented as n (%), as appropriate. Patients were matched as propensity score (PS) with the ratio of dialysis: non-dialysis = 1:1 according to age, male sex, BMI, smoking status, preoperative EF, CCS angina class, diabetes mellitus, hyperlipidemia, cardiac dysfunction, PAOD, liver insufficiency, cerebral deficits, number of grafts, complete revascularization, grafting strategy. Kaplan–Meier plot was performed and used log-rank test to compare late mortality between non-dialysis and dialysis patients. Late mortality was identified as death after discharge, and the follow-up duration was estimated from surgery date to the last visit or death. A two-sided P-value of < 0.05 was regarded as statistically significant. Data management and statistical analyses were conducted with SAS version 9.4 software (SAS Institute, Inc.).
Anzeige
Results
Demographic characteristics
A total of 549 non-dialysis patients and 110 dialysis patients were included in this study (Table 1). Compared to dialysis patients, non-dialysis patients had significantly higher body mass index, higher proportions of male, current smoker, normal preoperative ejection fraction (EF), Canadian cardiovascular society (CCS) classes I and II, hyperlipidemia, complete revascularization, bilateral internal thoracic arteries grafting, and longer follow-up period. Non-dialysis patients also had significantly lower European system for cardiac operative risk evaluation (EuroSCORE), lower proportions of diabetes, cardiac dysfunction, peripheral artery occlusive disease (PAOD), liver insufficiency, and cerebral deficits. After PS matching, 89 non-dialysis patients and 89 dialysis patients were enrolled in the analysis. The characteristics between non-dialysis and dialysis groups were balanced, except EuroSCORE and follow-up period. Non-dialysis patients still had lower additive and logistic score and longer follow-up period.
Table 1
Baseline characteristics of the study population before and after matching
Characteristic
Before matching
After matching
Non-dialysis patients
Dialysis patients
P-value
Non-dialysis patients
Dialysis patients
P-value
(N = 549)
(N = 110)
(N = 89)
(N = 89)
Age, years
63.00 (57.00–69.00)
62.00 (55.00–67.00)
0.065
62.94 ± 9.57
62.69 ± 9.08
0.854
Male sex
443 (80.69%)
74 (67.27%)
0.002
63 (70.79%)
64 (71.91%)
0.868
BMI, kg/m2
25.92 (23.46–28.40)
24.58 (22.03–26.44)
< .001
24.28 (21.91–27.34)
24.80 (22.43–26.40)
0.671
EuroSCOREa
Additive
4.00 (2.00–7.00)
8.00 (5.50–10.00)
< .001
6.00 (3.00–9.00)
8.00 (5.00–10.00)
0.005
Logistic
2.59 (1.32–6.21)
8.91 (4.73–17.60)
< .001
4.58 (2.24–11.94)
7.62 (4.10–15.20)
0.010
Year of surgery
0.123
0.462
2009–2010
71 (12.93%)
9 (8.18%)
13 (14.61%)
7 (7.87%)
2011–2012
121 (22.04%)
15 (13.64%)
17 (19.1%)
12 (13.48%)
2013–2014
98 (17.85%)
24 (21.82%)
19 (21.35%)
22 (24.72%)
2015–2016
105 (19.13%)
26 (23.64%)
15 (16.85%)
18 (20.22%)
2017–2019
154 (28.05%)
36 (32.73%)
25 (28.09%)
30 (33.71%)
Smoking status
< .001
> 0.999
Never-smoker
354 (64.48%)
95 (86.36%)
75 (84.27%)
75 (84.27%)
Ex-smoker
71 (12.93%)
4 (3.64%)
5 (5.62%)
4 (4.49%)
Current smoker
124 (22.59%)
11 (10.00%)
9 (10.11%)
10 (11.24%)
Preoperative EF, %
< .001
0.921
> 50, normal LV function
385 (70.13%)
52 (47.27%)
48 (53.93%)
47 (52.81%)
40–50, mild LV dysfunction
77 (14.03%)
26 (23.64%)
18 (20.22%)
19 (21.35%)
30–40, moderate LV dysfunction
52 (9.47%)
21 (19.09%)
18 (20.22%)
16 (17.98%)
< 30, severe LV dysfunction
35 (6.38%)
11 (10%)
5 (5.62%)
7 (7.87%)
Postoperative EF, %
0.080
0.455
> 50, normal LV function
370 (67.4%)
60 (54.55%)
48 (53.93%)
50 (56.18%)
40–50, mild LV dysfunction
83 (15.12%)
24 (21.82%)
17 (19.1%)
20 (22.47%)
30–40, moderate LV dysfunction
50 (9.11%)
13 (11.82%)
9 (10.11%)
11 (12.36%)
< 30, severe LV dysfunction
46 (8.38%)
13 (11.82%)
15 (16.85%)
8 (8.99%)
CCS Angina Class
0.001
0.887
I or II
141 (25.68%)
19 (17.27%)
17 (19.1%)
15 (16.85%)
III
210 (38.25%)
30 (27.27%)
26 (29.21%)
25 (28.09%)
IV
198 (36.07%)
61 (55.45%)
46 (51.69%)
49 (55.06%)
Comorbidities
Diabetes mellitus
307 (55.92%)
78 (70.91%)
0.004
55 (61.8%)
62 (69.66%)
0.269
Hypertension
422 (76.87%)
89 (80.91%)
0.354
68 (76.4%)
73 (82.02%)
0.356
Hyperlipidemia
341 (62.11%)
38 (34.55%)
< .001
33 (37.08%)
34 (38.2%)
0.877
COPD
19 (3.46%)
1 (0.91%)
0.225
3 (3.37%)
1 (1.12%)
0.621
Cardiac dysfunction
107 (19.49%)
31 (28.18%)
0.041
27 (30.34%)
23 (25.84%)
0.505
Renal dysfunction
17 (3.1%)
4 (3.64%)
0.7659
7 (7.87%)
4 (4.49%)
0.350
PAOD
12 (2.19%)
14 (12.73%)
< .001
6 (6.74%)
7 (7.87%)
0.773
Liver insufficiency
23 (4.19%)
10 (9.09%)
0.031
8 (8.99%)
6 (6.74%)
0.578
Cerebral deficits
48 (8.74%)
20 (18.18%)
0.003
17 (19.1%)
17 (19.1%)
> 0.999
Number of grafts
0.005
0.969
1
17 (3.1%)
0 (0%)
-
-
2
45 (8.2%)
11 (10%)
10 (11.24%)
9 (10.11%)
3
112 (20.4%)
37 (33.64%)
26 (29.21%)
26 (29.21%)
≥ 4
375 (68.31%)
62 (56.36%)
53 (59.55%)
54 (60.67%)
Complete revascularization b
485 (89.48%)
89 (80.91%)
0.012
73 (82.02%)
73 (82.02%)
> 0.999
Grafting Strategy
< .001
0.541
NO ITA
39 (7.1%)
5 (4.55%)
6 (6.74%)
4 (4.49%)
SITA
352 (64.12%)
93 (84.55%)
75 (84.27%)
73 (82.02%)
BITA
158 (28.78%)
12 (10.91%)
8 (8.99%)
12 (13.48%)
IABP use
119 (21.68%)
25 (22.73%)
0.808
26 (29.21%)
17 (19.1%)
0.115
Years of follow-up
3.88 (1.61–7.00)
2.24 (0.73–4.01)
< .001
4.57 (1.15–6.84)
2.14 (0.73–4.13)
0.001
Significant values are showing in bold
Continuous data without normal distribution were presented as median (IQR) and categorical data were presented as n (%)
SD Standard deviation, IQR Interquartile range, BMI body mass index, EuroSCORE European system for cardiac operative risk evaluation, CABG coronary artery bypass graft surgery, EF ejection fraction, LITA left internal thoracic artery, LAD left anterior descending artery, LV left ventricular, CCS Canadian cardiovascular society, COPD chronic obstruction pulmonary disease, PAOD peripheral artery occlusive disease, BITA blateral internal thoracic arteries, MI myocardial infarction, PCI percutaneous coronary intervention, RCA right coronary artery, LCX left circumflex coronary artery, SVG saphenous vein graft, IABP intra-aortic balloon pump
aThere were 502 patients in the non-dialysis group and 104 patients in the dialysis group. 53 of patients were missing in all study population; 11 of patients were missing after matching
b7 of patients were missing in all study population
The outcomes after CABG between non-dialysis and dialysis patients after PS matching are presented in Table 2. After CABG, dialysis group had significantly higher longer length of stay (14 (11–18) vs 11 (9–14) days, p = 0.016), post-CABG MI frequency (16.85% vs. 6.74%, p = 0.037), and mortality rate (25.93% vs 9.41%, p = 0.005) than non-dialysis group. No significant differences in in-hospital mortality, surgical complications or post-CABG reintervention were observed between groups. Figure 1 presents the crude survival curves excluded in-hospital death. A significantly lower survival during follow-up was observed in dialysis group compared to the non-dialysis group (p < 0.001 with long rank test).
Table 2
Postoperative outcomes of the study population after PSM
Variable
Non-dialysis patients
Dialysis patients
P-value
(N = 89)
(N = 89)
Short-term outcomes
In-hospital mortality
4 (4.49%)
8 (8.99%)
0.232
Length of hospital stay for surgery, days
12 (10–15)
14 (11–18)
0.016
Surgical complications
Cardiac
3 (3.37%)
3 (3.37%)
> 0.999
Non-cardiac
26 (29.21%)
24 (26.97%)
0.739
Sepsis
3 (3.37%)
4 (4.49%)
> 0.999
Wound infection
8 (8.99%)
4 (4.49%)
0.232
Respiratory failure
4 (4.49%)
7 (7.87%)
0.350
Hyperkalemia
3 (3.37%)
2 (2.25%)
> 0.999
Gastrointestinal bleeding
1 (1.12%)
2 (2.25%)
> 0.999
Stroke
3 (3.37%)
2 (2.25%)
> 0.999
Reoperation for hemorrhage control
5 (5.62%)
8 (8.99%)
0.387
Requiring ventilation > 24 h
9 (10.11%)
7 (7.87%)
0.600
Long-term outcomes
Postoperative outcome
Recurrent angina
17 (19.1%)
12 (13.48%)
0.310
Post-CABG MI
6 (6.74%)
15 (16.85%)
0.037
Post-CABG reintervention
16 (17.98%)
20 (22.47%)
0.455
PCI for failed LAD graft
6 (6.74%)
4 (4.49%)
0.515
PCI for non-CABG RCA or LCX
7 (7.87%)
10 (11.24%)
0.444
PCI for failed SVG graft
8 (8.99%)
14 (15.73%)
0.172
Late mortalitya
8 (9.41%)
21 (25.93%)
0.005
Significant values are showing in bold
Continuous data without normal distribution are presented as median (IQR) and categorical data are presented as n (%)
aPatients died in hospital were not included in the analysis
Fig. 1
Crude survival rate including all death. A low survival curve was observed in dialysis patients during follow-up compared to non-dialysis patients (Long rank test, p < 0.001)
×
The outcomes of dialysis patients after CABG are presented in Table 3, including 99 patients with HD and 11 patients with peritoneal dialysis (PD). The in-hospital mortality was 7.07% in HD patients and 18.18% in PD patients (p = 0.222). No significant differences were found between the two groups, except the PD group had more cardiac complications than the HD group (18.18% vs 2.02%, p = 0.049).
Table 3
Postoperative outcomes of the dialysis patients
Characteristic
HD
PD
P-value
(N = 99)
(N = 11)
In-hospital mortality
7 (7.07%)
2 (18.18%)
0.222
Length of stay for surgery, days
14 (11–19)
12 (10–15)
0.081
Complications
Cardiac
2 (2.02%)
2 (18.18%)
0.049
Non-cardiac
28 (28.28%)
3 (27.27%)
> 0.999
Sepsis
5 (5.05%)
0 (0%)
> 0.999
Wound infection
6 (6.06%)
0 (0%)
> 0.999
Respiratory failure
7 (7.07%)
1 (9.09%)
0.582
Hyperkalemia
2 (2.02%)
0 (0%)
> 0.999
Gastrointestinal bleeding
2 (2.02%)
0 (0%)
> 0.999
Stroke
2 (2.02%)
0 (0%)
> 0.999
Reoperation for hemorrhage control
9 (9.09%)
1 (9.09%)
> 0.999
Requiring ventilation > 24 h
9 (9.09%)
1 (9.09%)
> 0.999
Major adverse cardiac events
Late mortality
24 (24.24%)
2 (18.18%)
> 0.999
Significant values are showing in bold
Continuous data are presented as median were median (IQR) and categorical data are presented as n (%)
Discussions
The results of the present study, dialysis patients had significantly worse outcomes compared to non-dialysis patients after on-pump beating-heart CABG, including longer length of stay, higher rate of post-CABG MI, and lower survival during follow-up. However, no significant differences in in-hospital mortality, surgical complications, or revascularization rate during follow-up were observed between dialysis and non-dialysis groups. Our results show that on-pump beating-heart CABG is a safe and effective option for dialysis patients.
In the present study, no significant differences in in-hospital mortality, surgical complications, or post-CABG reintervention during follow-up was observed between dialysis and non-dialysis patients. Dialysis is known as an independent risk factor for surgical mortality after CABG [1, 3‐5]. Our results showed on-pump beating-heart CABG could achieve comparable short-term surgical outcomes in dialysis patients as those in non-dialysis patients. Meanwhile, Chen et al. reported a higher risk for revascularization after CABG in dialysis patients than non-dialysis patients [3]. It is well-recognized that on-pump CABG ensures comprehensive revascularization [7, 8]. Our result showed that on-pump beating-heart CABG achieves good long-term revascularization also in dialysis group. These results together show that it is a safe and effective option for dialysis patients.
Our results showed that dialysis patients had a significantly longer length of stay, higher rate of MI, and poorer survival after CABG compared to non-dialysis patients. Dialysis is significantly associated with poor outcomes after cardiac surgery [1‐5], and the risk for mortality is elevated as dialysis-dependence duration extends [1, 3]. Studies have reported that dialysis patients show significantly higher 30-day mortality, readmission rate, rates of postoperative MI or revascularization, and lower survival after CABG compared to non-dialysis patients [1‐5]. CABG is not associated with short-term mortality but improves life expectancy of dialysis patients [5, 9, 10]. For better prognosis, more attention must be paid on dialysis patients’ postoperative conditions after CABG, including monitoring cardiovascular stability, and education of self-care for patients and caregivers.
In the present study, PD patients showed twofold higher in-hospital mortality compared to HD patients without statistically significant difference (2/12 vs. 7/115, p = 0.222) probably due to the limited sample size. Studies reported that PD patients were prone to higher in-hospital mortality than HD patients after CABG [11, 12]. Further study is needed to clarify the underlying mechanism.
Limitation
The study had some limitations. First, it is a retrospective study with those inherent limitations. Second, the study had small sample size and unequal distribution of patients across the dialysis and non-dialysis groups, which may skew the analysis of outcomes. Therefore, PS matching analysis was employed to account for these variables.
Anzeige
Conclusion
After on-pump beating-heart CABG, dialysis patients have longer length of stay, higher rate of postoperative MI, and poor survival; whereas no significant differences in in-hospital mortality or revascularization rate during follow-up between dialysis and non-dialysis patients. Our findings show that on-pump beating-heart CABG could achieve comparable surgical mortality and good long-term revascularization in dialysis patients as those in non-dialysis patients. It is a safe and effective option for dialysis patients.
Acknowledgements
None.
Declarations
Ethics approval and consent to participate
The study was approved by the institutional review board of Shin Kong Wu Ho-Su Memorial Hospital (No.20220703R), and informed consent was waived by the institutional review board of Shin Kong Wu Ho-Su Memorial Hospital. All methods were carried out in accordance with relevant guidelines and regulations
Consent for publication
Not applicable
Anzeige
Competing interests
The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Short-term and long-term outcomes of on-pump beating-heart coronary artery bypass surgery in dialysis and non-dialysis patients: a retrospective study in a single center
verfasst von
Chia-Hsun Lin Yen‐Yang Chen Yu‐Tong Yen Patrick Hung‐Ju Kao Chai-Hock Chua Hung-Hsing Chao Ming-Jen Lu
Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.
Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.
Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
